Sunny Al-Shamma
Director Ejecutivo en Beacon Discovery, Inc. .
Cargos activos de Sunny Al-Shamma
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Beacon Discovery, Inc.
 Beacon Discovery, Inc. BiotechnologyHealth Technology Beacon Discovery, Inc. is a world leader in GPCR-focused drug discovery. The private company is based in San Diego, CA. The company's mission is to efficiently identify and advance molecules targeting GPCRs from concept to clinic. In addition, Beacon collaborates with biopharma partners to leverage internally enabled GPCR targets and small molecule modulators as well as its wealth of GPCR discovery skills and tools. The CEO of the company is Sunny Al-Shamma. | Director Ejecutivo | - | - |
| Presidente | - | - | |
| Presidente | - | - | |
Eurofins Panlabs, Inc.
 Eurofins Panlabs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Panlabs, Inc. is a company that provides molecular pharmacology, functional pharmacology, cellular services and informatics analytics. The company is based in Saint Charles, MO. The company was founded in 2012. The CEO is Sunny Al-Shamma. | Director Ejecutivo | - | - |
| Presidente | - | - |
Historial de carrera de Sunny Al-Shamma
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Chief Executive Officer | 2 |
| President | 2 |
| Chairman | 1 |
Sectorial
| Commercial Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Eurofins Panlabs, Inc.
Eurofins Panlabs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Eurofins Scientific SE, Eurofins Panlabs, Inc. is a company that provides molecular pharmacology, functional pharmacology, cellular services and informatics analytics. The company is based in Saint Charles, MO. The company was founded in 2012. The CEO is Sunny Al-Shamma. | Commercial Services |
Beacon Discovery, Inc.
Beacon Discovery, Inc. BiotechnologyHealth Technology Beacon Discovery, Inc. is a world leader in GPCR-focused drug discovery. The private company is based in San Diego, CA. The company's mission is to efficiently identify and advance molecules targeting GPCRs from concept to clinic. In addition, Beacon collaborates with biopharma partners to leverage internally enabled GPCR targets and small molecule modulators as well as its wealth of GPCR discovery skills and tools. The CEO of the company is Sunny Al-Shamma. | Health Technology |
- Bolsa de valores
- Insiders
- Sunny Al-Shamma
- Experiencia
